SCHEMBL6491308

SCHEMBL6491308

Ic1ccc2nc(-c3ccccc3)cn2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 8/20 0.69
ALDH1A1 P00352 6/20 0.69
ALDH1A2 O94788 1/20 0.69
APP P05067 3/20 0.65
NPC1 O15118 9/20 0.65
RAB9A P51151 9/20 0.65
KDM4E B2RXH2 5/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
HPGD P15428 3/20 0.65
KMT2A Q03164 2/20 0.65
PKM P14618 2/20 0.65
TP53 P04637 1/20 0.65
TSHR P16473 1/20 0.65
CDK5 Q00535 1/20 0.65
CDK5R1 Q15078 1/20 0.65
HSD17B10 Q99714 1/20 0.65
SLC2A1 P11166 1/20 0.61
POLB P06746 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15177306 0.89 APP (0.73) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL24320031 0.84 NPC1 (0.74) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL26603206 0.83 APP (0.69) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL2904371 0.83 APP (0.66) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL1985593 0.83 APP (0.66) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL1726415 0.83 APP (0.66) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL217156 0.83 RAB9A (0.75) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL26603213 0.82 APP (0.54) ALDH1A3ALDH1A1ALDH1A2APPNPC1
SCHEMBL13325768 0.81 ALDH1A3 (1.00) ALDH1A3ALDH1A1ALDH1A2NPC1RAB9A
Bromide SCHEMBL1726261 0.81 NPC1 (0.65) ALDH1A3ALDH1A1ALDH1A2APPNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250283038-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-09-11 US claimed
EP-4511027-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS Université Paris Cité (FR) 2025-02-26 EP claimed
WO-2023203163-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS UNIVERSITE PARIS CITE (FR) 2023-10-26 WO claimed
EP-4265248-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS Université Paris Cité (FR) 2023-10-25 EP claimed
US-20250283038-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2025-09-11 US disclosed
EP-4511027-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS Université Paris Cité (FR) 2025-02-26 EP disclosed
US-20240034723-A1 PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-02-01 US disclosed
WO-2023203163-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS UNIVERSITE PARIS CITE (FR) 2023-10-26 WO disclosed
WO-2023203163-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS UNIVERSITE PARIS CITE (FR) 2023-10-26 WO disclosed
EP-4265248-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS Université Paris Cité (FR) 2023-10-25 EP disclosed
EP-4265248-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS Université Paris Cité (FR) 2023-10-25 EP disclosed
CN-116669769-A Piperidinyl small molecule degradants of HELIOS and methods of use 达纳-法伯癌症研究所公司 2023-08-29 CN disclosed
EP-4228651-A1 PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE Dana-Farber Cancer Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081976-A1 PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-04-21 WO disclosed
CN-109651363-B Aminomethylated imidazo [1,2-a ] pyridine compound and preparation method thereof 东华理工大学 2020-06-26 CN disclosed
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP ALDH1A3 785/4885ALDH1A1 1577/4885ALDH1A2 1056/4885
US-20250283038-A1 COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS CXCL10, IL2, IFNG ALDH1A3 3585/4885ALDH1A1 2221/4885ALDH1A2 3347/4885
US-20240034723-A1 PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE IKZF2, IKZF1, NUTF2 ALDH1A3 2094/4885ALDH1A1 2101/4885ALDH1A2 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.